COST/UTILITY ANALYSIS (CUA) OF VALSARTAN FOR THE TREATMENT OF CONGESTIVE HEART FAILURE (CHF) IN ITALY BASED ON THE VAL-HEFT TRIAL

被引：0
|
作者：
Pradelli, L. [1 ]
Iannazzo, S. [1 ]
Zaniolo, O. [1 ]
机构：
[1] AdRes Srl, Turin, Italy
来源：
VALUE IN HEALTH | 2008年 / 11卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)66370-X
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A403 / A404
页数：2
相关论文
共 50 条
  • [1] Val-HeFT to investigate Valsartan in treatment of congestive heart failure
    不详
    CANADIAN JOURNAL OF CARDIOLOGY, 1997, 13 (10) : 971 - 972
  • [2] Val-HeFT - Valsartan in heart failure trial - Population characteristics
    Cohn, JN
    Tognoni, G
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 211A - 211A
  • [3] Effect of valsartan on hospitalization rate in valsartan-heart failure trial (Val-HeFT)
    Cohn, JN
    Anand, IS
    Carson, P
    Holwerda, NJ
    Stumpe, K
    Majahalme, S
    Maggioni, A
    Latini, R
    Tognoni, G
    CIRCULATION, 2001, 104 (17) : 594 - 594
  • [4] Improving outcomes in congestive heart failure: Val-HeFT
    Cohn, JN
    CARDIOLOGY, 1999, 91 : 19 - 22
  • [5] Efficacy of valsartan in elderly heart failure patients in Val-HeFT
    Baruch, L
    Heywood, T
    Krum, H
    Anand, I
    Glazer, R
    Cohn, JN
    CIRCULATION, 2002, 106 (19) : 685 - 685
  • [6] The benefits. of valsartan in the treatment of heart failure: results from Val-HeFT
    Tan, LB
    Schlosshan, D
    Williams, SG
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2004, 58 (02) : 184 - 191
  • [7] Valsartan reduces the incidence of atrial fibrillation in the patients with heart failure in the Val-HeFT trial
    Maggioni, AP
    Latini, R
    Carson, PE
    Singh, SN
    Barlera, S
    Tognoni, G
    Cohn, JN
    CIRCULATION, 2003, 108 (17) : 507 - 508
  • [8] Valsartan reduces the incidence of atrial fibrillation in patients with heart failure:: Results from the Valsartan Heart Failure Trial (Val-HeFT)
    Maggioni, AP
    Latini, R
    Carson, PE
    Singh, SN
    Barlera, S
    Glazer, R
    Masson, S
    Cerè, E
    Tognoni, G
    Cohn, JN
    AMERICAN HEART JOURNAL, 2005, 149 (03) : 548 - 557
  • [9] Multinational economic evaluation of valsartan in patients with chronic heart failure: Results from the Valsartan Heart Failure Trial (Val-HeFT)
    Reed, SD
    Friedman, JY
    Velazquez, EJ
    Gnanasakthy, A
    Califf, RM
    Schulman, KA
    AMERICAN HEART JOURNAL, 2004, 148 (01) : 122 - 128
  • [10] Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure - The Valsartan Heart Failure Trial (Val-HeFT)
    Latini, R
    Masson, S
    Arland, I
    Judd, D
    Maggioni, AP
    Chiang, YT
    Bevilacqua, M
    Salio, M
    Cardano, P
    Dunselman, PHJM
    Holwerda, NJ
    Tognoni, G
    Cohn, JN
    CIRCULATION, 2002, 106 (19) : 2454 - 2458
12345